Paradigm Biopharma – executive interview - Paul Rennie, CEO, co-founder and chairman, Paradigm Biopharmaceuticals Ltd 00:00:00

Share On Facebook Share On Twitter

Paradigm Biopharma is an Australian biotechnology company focused on the development of injectable pentosan polysulfate (iPPS).

Recent Videos